Insys Therapeutics founder John Kapoor leaves federal court in Boston earlier this year. This marks the first time a drugmaker has turned to bankruptcy court to contend with legal expenses incurred by its role in the nation’s deadly opioid epidemic. Kapoor’s conviction also marks the first time the head of a drug company will face serious jail time for furthering the opioid crisis. The government will be an unsecured creditor in the bankruptcy case, and Insys will ask the court to cap the federal settlement at $190 million. Purdue Pharma, maker of OxyContin, is reportedly mulling bankruptcy as it fends off lawsuits from several states tied to the opioid epidemic.

Source: Washington Post June 10, 2019 15:29 UTC